Related Experiment Videos
Summary
Many cancer patients experience significant pain relief from placebo, indicating a strong psychological component in pain management. Those who respond to placebo also show better results with active pain medications.
Area of Science:
- Oncology
- Pain Management
- Psychosomatic Medicine
Background:
- Placebo effect is a well-documented phenomenon in clinical trials.
- Understanding factors influencing placebo response is crucial for optimizing pain management strategies in cancer patients.
Purpose of the Study:
- To investigate the prevalence and characteristics of placebo responders among cancer patients undergoing oral analgesic trials.
- To identify demographic and psychosocial factors associated with placebo responsiveness.
Main Methods:
- Controlled trial of oral analgesics involving 288 cancer patients.
- Assessment of pain relief from placebo formulations.
- Analysis of demographic data and side effect incidence.
Main Results:
- 112 out of 288 patients (39%) achieved >=50% pain relief with placebo.
- Placebo responders demonstrated higher response rates to active drugs and increased central nervous system side effects.
- Factors associated with higher placebo response included higher education, professional occupations, and specific marital statuses.
- Factors associated with lower placebo response included lower education, unskilled labor, and smoking.
Conclusions:
- Placebo response in cancer pain management is significant and influenced by various patient characteristics.
- The findings suggest a potential link between placebo response, autohypnosis, and oral dependency needs.
- Individual self-sufficiency and the dependency of illness may heighten vulnerability to placebo effects.